The Election is (Mostly) Decided – How It Impacts Healthcare in North Texas

It’s been a week since the election, and many may be wondering how the results will change the healthcare industry, if at all. Clearly top of mind for many, a Deloitte study said that 26 percent of voters said healthcare was their top issue and three out of four voters who responded that way voted for Democrats. We touched base with John McCracken, clinical professor of healthcare management at The University of Texas at Dallas Jindal School of Management and adjunct professor of family and community medicine at UT Southwestern Medical Center and Thaddeus Miller, associate professor in the University of… Full Story

Becker’s Hospital Review Recognizes Two Local Health Systems for Innovation

Becker’s Healthcare compiled a list of health systems who push the envelope for healthcare innovation, and Baylor and UT Southwestern were both named to it. For these hospitals, developing new technology and techniques is not just a coincidence. They dedicate departments, funding, and organization to research and the incorporation of technology into the medical field. Patents for medical devises, mobile health, process design, and care delivery are other areas where these systems excel, according to Becker’s. Baylor Scott and White’s Office of Digital Health and Technology Transfer Office both made the list. In the Digital Office, Becker’s highlighted their patient… Full Story

See What’s Next in Healthcare Innovation at Health Wildcatters Pitch Day This Week

The North Texas healthcare innovation marketplace is a growing one, and Health Wildcatters is helping lead the charge. The healthcare accelerator was recently ranked as one of Seed Accelerator’s top companies for the third year in a row. Health Wildcatters pitch day for their fall cohort will take place this Thursday at the Majestic Theater. The pitch day costs $10 and will include pitches from six up-and-coming innovators and keynote address by Dr. David Albert, the founder and chief medical officer at AliveCor, a medical device and artificial intelligence company whose devices measures the electrical activity of the heart via mobile… Full Story

Local Researchers Identify Marker for Patients at Risk of Immunotherapy Side Effects

UT Southwestern researchers may have moved closer to identifying patients at greatest risk of side effects from immunotherapy treatments. Immunotherapy mobilizes the patient’s immune system to fight cancer, and researchers found that there are molecules called cytokines that signal the immune system to fire up to fight disease. If cytokines are low in a patient, that patient is more likely to develop immune-related side effects. The studies focused on a variety of cancer types and widely used immunotherapy drugs and were funded from a grant from the American Cancer Society. They will expand to multicenter clinical trials to look at… Full Story

FDA Approves New Flu Medication, Hoping to Combat Last Year’s Deadly Flu Season in North Texas

As this year’s flu season ramps up, the FDA approved a flu medication with a new mechanism of action for the first time in 20 years. For those who are 12 years or older and have had acute, uncomplicated flu for less than 48 hours, Xofluza (baloxavir marboxil) could be the new answer. Last year, the flu vaccine was only effective in 40 percent of cases, and the Centers for Disease Control estimates that there were more than 900,000 hospitalizations and 80,000 deaths due to the flu since 2010. Each year, an estimated 3 to 11 percent of the U.S. population gets the… Full Story

Health Wildcatters Ranked as a Top Accelerator for the Third Year in a Row

Dallas is home to one of the top accelerators in the country, as Health Wildcatters has been highly ranked by the Seed Accelerator Rankings Project for the third year in a row. SARP is a study conducted by MIT, the University of Richmond, and Rice University, and is meant to promote further discussion about the impacts and prospects of the accelerator world. The rankings help clarify which programs are performing in regards to funding, valuations, alumni feedback, and survival rates, providing valuable information to entrepreneurs trying to decide where to take their ideas. Health Wildcatters accelerator program focuses exclusively on healthcare entrepreneurs.… Full Story

What Did We Learn at the D CEO Healthcare Breakfast Panel?

Last Thursday, D CEO Healthcare hosted a packed house full of healthcare professionals to discuss the future of cancer care in North Texas. We had four panelists who elaborated on everything from immunotherapy to how big data is impacting cancer care. With a view from the 21st floor of 750 North St. Paul and several varieties of quiche, it made for a cozy and informative breakfast panel. Our panelists were Dr. Carlos Arteaga, Director, Simmons Comprehensive Cancer Center at UT Southwestern; Dr. Ted Laetsch, Associate Professor at UT Southwestern, and Director of Experimental Therapeutics Program, Gill Center for Cancer and Blood Disorders at… Full Story

UTSW Researchers One Step Closer to Stopping Disease Causing Thousands of Painful Tumors

Imagine having a condition that covers your body with thousands of small tumors. Not only are they disfiguring, but they itch, are painful, catch on your clothing, bleed, and can become infected. The only thing worse than the physical pain is the emotional distress of trying to hide them, if possible. The condition is called neurofibromatosis type 1, and occurs in one in 3,000 people. UT Southwestern researchers have created a model and identified a marker for the cell of origin for NF1 tumors, allowing them to learn more about how they form and possibly slow their growth. “Because of this model,… Full Story

Meet D CEO Healthcare Panelist Dr. Theodore Laetsch

Dr. Theodore Laetsch is on the leading edge of fighting blood cancer in children. He was recently the lead investigator for a Novartis study where his team genetically engineered T-cells to fight the leukemia cells with substantial results, and will be one of our panelists at our D CEO Healthcare Breakfast next week. UT Southwestern and Children’s Health partnered to be one of 13 clinical trial locations for the study, which entailed removing blood from the patient, inserting a gene into the T-cells that fight illness to target the leukemia when they were put back into the patient. These Chimeric… Full Story

The First Spina Bifida Open Fetal Surgery in North Texas

North Texas’s first spina bifida open fetal surgery occurred this summer at The Fetal Care Center in Medical City Children’s Hospital, when Dr. Timothy Crombleholme operated on Uriah Powell while he was still his in his mother’s womb. Shawn Shinneman wrote about Crombleholme’s journey to Dallas and how fetal surgery arrived in North Texas in October’s D Magazine. When Uriah was born, his kicking legs signaled a successful spina bifida surgery. When Uriah’s mother Sarah was 18 weeks pregnant, she found he had spina bifida, a birth defect caused when the spine and spinal cord do not form properly, exposing a… Full Story